Agartala, Tripura – A recent report on HIV has sent shockwaves through the state of Tripura, revealing that 828 students have tested positive for the virus, with 47 fatalities recorded. According to a senior official from the Tripura State AIDS Control Society, of these 828 students, 572 are still alive, while 47 have succumbed to the disease, with many students having migrated out of Tripura for higher education opportunities at prestigious institutions across the country.
The Tripura AIDS Control Society has pinpointed students from 220 schools and 24 colleges and universities engaging in injectable drug use. The Joint Director of TSACS highlighted that affluent families often discover their children’s drug addiction too late, as parents may not initially recognize the warning signs, resulting in devastating consequences.
Intravenous drug abuse plays a significant role in the global health crisis of HIV/AIDS, with the sharing of needles being a primary mode of transmission. Risky injection practices, coupled with limited access to sterile needles, contribute to the spread of the virus among drug-using populations. Efforts to combat this issue include harm reduction strategies like needle exchange programs, which aim to reduce infection risk through the provision of sterile equipment and support services.
As of May 2024, 8,729 individuals have been registered at Antiretroviral Therapy (ART) centers in Tripura, with 5,674 currently living with HIV. ART, a combination of medications that suppress viral replication in the body, is crucial in managing HIV/AIDS by maintaining low viral loads and preserving immune function. Adherence to ART is essential for its effectiveness, allowing individuals with HIV to lead longer, healthier lives.
Addressing the intersection of HIV and intravenous drug use requires comprehensive approaches that integrate public health initiatives, social services, and community engagement. Despite challenges such as stigma and legal barriers, efforts to mitigate risks and support affected individuals are ongoing. Continued research aims to improve ART regimens for better outcomes and reduced side effects, demonstrating the ongoing commitment to combating the HIV epidemic in Tripura.